A single institutional experience with 43 pregnancies in essential thrombocythemia (Q28183482)

European Journal of Haematology

Europe PubMed Central

title

A single institutional experience with 43 pregnancies in essential thrombocythemia (English)

0 references

2

A Tefferi

0 references

author name string

C A Wright

series ordinal

1

0 references

language of work or name

English

0 references

publication date

March 2001

0 references

published in

0 references

volume

66

0 references

page(s)

152-9

0 references

issue

3

0 references

cites work

Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2001.00367.X

Age and sex distributions of hematological malignancies in the U.K.

21 April 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

No treatment for low-risk thrombocythaemia: results from a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Essential thrombocythemias. Clinical evolutionary and biological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Outcome analysis of 34 pregnancies in women with essential thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Primary thrombocythaemia in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Clinical manifestations of essential thrombocythemia in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Essential thrombocythemia in pregnancy: Platelet count and pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Effective measures for the prevention of late abortions and premature births

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Thrombosis in pregnancy: maternal and fetal issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Affinity purified human antiphospholipid antibodies bind normal term placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Essential thrombocythemia in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Treatment of polycythaemia vera and essential thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Platelet counts during normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Essential thrombocythemia and complications of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Essential thrombocythemia during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Interferon-alpha therapy in polycythemia vera and essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Treatment of essential thrombocythemia during pregnancy: antiabortive effect of interferon-α?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Should a platelet limit of 600 x 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

Life expectancy of patients with chronic nonleukemic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Clinical course of essential thrombocythemia in 147 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Essential thrombocythemia associated with recurrent abortions and fetal growth retardation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Essential thrombocythemia and pregnancy: a report of six normal pregnancies in five untreated patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Three successful pregnancies in a woman with essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Endocrine factors associated with recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Recurrent miscarriage: overview and recommendations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Primary thrombocythemia in pregnancy: A report of two cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Postpartum thrombosis in primary thrombocythaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Essential thrombocythemia and pregnancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Essential thrombocythaemia is not associated with postpartum thrombosis or an increased risk of venous thromboembolism. Thrombocythemia Vera Study Group and European Working Group on Myeloproliferative Disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Spontaneous remission during two pregnancies in a patient with essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Idiopathic thrombocythemia and pregnancy; a case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Normal pregnancy in a patient with essential thrombocythemia treated with interferon-alpha 2b

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Alpha 2b-interferon therapy and pregnancy--report of a case of essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Successful treatment of essential thrombocythemia with alpha interferon during pregnancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Childbearing age patients with essential thrombocythemia: should they be placed on interferon?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021

Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00367.X

7 January 2021